Avalon Pharma, Bio-Thera reach license agreements for BAT3306 in MENA
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) entered into a strategic commercialization agreement with Bio-Thera Solutions to register Pembrolizumab in Saudi Arabia and MENA markets Under the agreement, …